CNBC’s “Squawk Box” team discusses progress on the coronavirus vaccine front. Moderna’s mRNA vaccine was just announced to have a 94.5% efficacy rate. Dr. Scott Gottlieb, former FDA commissioner and board member of Illumina and Pfizer, discusses how it will affect the economic recovery and public health efforts.